Clinical trial
An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of…
NCT00237458 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00237458 |
|---|---|
| Title | An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain |
| Official title | An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Refractory Neuropathic Pain |
| Intervention type | Drug |
| Interventions | Lacosamide |
| Enrollment | 7 |
| Start date | May 1, 2001 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Oct 12, 2005 |
| Last update posted | Aug 28, 2017 |
| Countries | Germany |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: